• Adipotide Peptide for Fat Reduction - Effective Weight Loss Solution | STTMY
  • Adipotide Peptide for Fat Reduction - Effective Weight Loss Solution | STTMY
  • Adipotide Peptide for Fat Reduction - Effective Weight Loss Solution | STTMY
  • Adipotide Peptide for Fat Reduction - Effective Weight Loss Solution | STTMY
  • Adipotide Peptide for Fat Reduction - Effective Weight Loss Solution | STTMY
  • Adipotide Peptide for Fat Reduction - Effective Weight Loss Solution | STTMY
  • Adipotide Peptide for Fat Reduction - Effective Weight Loss Solution | STTMY
  • Adipotide Peptide for Fat Reduction - Effective Weight Loss Solution | STTMY
  • Adipotide Peptide for Fat Reduction - Effective Weight Loss Solution | STTMY
  • Adipotide Peptide for Fat Reduction - Effective Weight Loss Solution | STTMY
  • Adipotide Peptide for Fat Reduction - Effective Weight Loss Solution | STTMY
  • Adipotide Peptide for Fat Reduction - Effective Weight Loss Solution | STTMY

Adipotide Peptide for Fat Reduction - Effective Weight Loss Solution | STTMY

Discover the power of Adipotide, a groundbreaking peptide designed to aid in fat reduction and promote effective weight loss. STTMY offers high-quality Adipotide to support your health and fitness goals.

Product name
Adipotide
Molecular formula
C152H252N44O42
Molecular weight
2611.41 g/mol
$15.00
  • Adipotide Peptide for Fat Reduction - Effective Weight Loss Solution | STTMY
  • Adipotide Peptide for Fat Reduction - Effective Weight Loss Solution | STTMY
  • Adipotide Peptide for Fat Reduction - Effective Weight Loss Solution | STTMY
  • Adipotide Peptide for Fat Reduction - Effective Weight Loss Solution | STTMY
  • Adipotide Peptide for Fat Reduction - Effective Weight Loss Solution | STTMY
  • Adipotide Peptide for Fat Reduction - Effective Weight Loss Solution | STTMY
Desciption

Adipotide Peptide for Effective Fat Reduction

Adipotide is a revolutionary peptide that targets fat cells, promoting their elimination and aiding in significant weight loss. Designed for those seeking a scientific approach to weight management, Adipotide offers a unique solution for reducing unwanted fat.

How Adipotide Works

Adipotide works by selectively targeting and inducing apoptosis in the blood vessels supplying fat cells. This process leads to the destruction of fat cells, resulting in a noticeable reduction in body fat. It’s an innovative approach that sets it apart from traditional weight loss methods.

Benefits of Using Adipotide

Users of Adipotide can expect several benefits, including:

  • Significant reduction in body fat
  • Targeted fat loss, especially in stubborn areas
  • Improved overall body composition
  • Support for weight management goals

Why Choose STTMY Adipotide?

STTMY is committed to providing high-quality peptides that meet the highest standards of purity and effectiveness. Our Adipotide peptide is thoroughly tested to ensure it delivers the best results for your weight loss journey.
What are the Effects?

Adipotide targets and breaks down fat cells by cutting off their blood supply.

What are the Benefits?

  1. Rapid Fat Loss: Quickly reduces body fat.
  2. Selective Action: Minimizes side effects.
  3. Non-Invasive: Safe alternative to surgery.
  4. Long-Term Results: Maintains fat loss.

How is This Product Different?

  1. Unique Mechanism: Directly targets fat cells.
  2. High Safety: Low risk of side effects.
  3. Professional Formula: Thoroughly tested.
  4. Stable Efficiency: Consistent results.


Our Service Advantages

Packaging and Delivery

Adipotide is carefully packaged to ensure its safety and integrity during transportation. Each vial is securely sealed and placed in a protective box, then packed in a robust shipping container to prevent any damage during transit. We use reliable courier services to deliver the product promptly and efficiently to your specified location.

Supply Ability

We maintain a consistent supply of Adipotide to meet the demands of our customers. With a production capacity that can handle large orders, we ensure that there is always a sufficient stock available. For bulk orders or special requirements, please contact our sales team to discuss your needs and receive a customized supply plan.

Lead Time

Our standard lead time for Adipotide orders is 5-7 business days, depending on the order size and destination. For larger orders, the lead time may be slightly longer, but we strive to fulfill all orders as quickly as possible. Once your order is placed, you will receive an estimated delivery date and regular updates on the status of your shipment.


FAQ

Q1: Can I get some samples?
A:Yes, we can supply the free sample, but the shipping cost be paid by our customers.
 
Q2: How to start orders or make payments?
A:Proforma invoice will be sent first after confirmation of order, enclosed our bank information. Payment by T/T, Western Union, Money Gram.
 
Q3: How to confirm the Product Quality before placing orders?
1.You can get free samples for some products,you only need to pay the shipping cost or arrange a courier to us and take the samples.
2. You can tell us your product specifications and requests,we will manufacture the products according to your requests.

Q4:Is there a discount?
A:Different quantity has different discount.

Q5: How do you treat quality complaint?
A:Our quality control will reduce the quality problem to near zero. If there is a real quality problem caused by us, we will send you free goods for replacement.

Q6:Do you Accept Sample Order?
A:Yes, we accept small order from 2mg, 5mg and 10mg to evaluate quality of our goods.

About US

Nestled in the heart of Henan Province, Zhengzhou Plastic Body Peptide Trading Co., Ltd embarked on its journey to redefine the chemical and pharmaceutical landscape. Founded on the principles of innovation, integrity, and excellence, we've dedicated ourselves to producing top-tier local anesthetics, pharmaceutical intermediates, steroids, and other crucial raw materials.

Driven by a passion for progress and a commitment to quality, our team has bridged continents, connecting with partners in North America, Eastern Europe, Southeast Asia, and beyond. Each product and solution we develop carries the mark of our rigorous research and customer-centric approach, aiming not just to meet but exceed global standards.




Adipotide FTPP Research


ADIPOTIDE FTPP MECHANISM OF ACTION

Adipotide has been suggested to exert action by binding to the receptors for two specific proteins, ANXA2 (Annexin A2) and prohibitin (PHB). It appears that these receptors may be expressed in a wide range of cells, but immunohistochemical analysis hypothesizes that they potentially form a unique ANXA2-prohibitin receptor system that are apparently found in white fat tissue.[2] It appears that these receptors were found on the endothelial cells of blood vessels that support white fat cells. Furthermore, research suggests that these receptors may play a role in regulating fatty acid transport in white adipose tissues (WAT).[3] To potentially explore this notion, the researchers disrupted the binding between ANXA2 and prohibitin genetically or by utilizing a blocking peptide. Their findings seem to indicate that the efficiency of fatty acid transport might depend on the interaction between ANXA2 and prohibitin. Moreover, the study suggests that the interaction between ANXA2 and prohibitin may facilitate the transport of fatty acids from the endothelium into adipocytes. The researchers also stumbled upon the revelation that ANXA2 and prohibitin form a complex alongside the fatty acid transporter CD36.
This intricate connection involving ANXA2, prohibitin, and CD36 potentially plays a role in mediating fatty acid transport in white adipose tissues. Furthermore, the researchers noticed that the coexistence of prohibitin and CD36 on the surface of adipocytes appears to be induced by extracellular fatty acids. This lead them to the hypothesis that the presence of fatty acids in the external environment may trigger the interaction between prohibitin and CD36 on the adipocyte surface. Hypothetically, inhibiting the ANXA2 protein may lead to hypertrophy of white adipose cells due to reduced uptake of fatty acids. On the other hand, prohibitin is a multifunctional membrane-associated protein that may be thought to regulate cell survival and growth. By shuttling from the cell’s membrane to its nucleus, it may hypothetically trigger apoptosis. Thus, the scientists commented that “suggest that an unrecognized biochemical interaction between ANX2 and PHB regulates CD36-mediated fatty acid transport in WAT, thus revealing a new potential pathway for intervention in metabolic diseases.”

ADIPOTIDE FTPP STRUCTURE

Adipotide appears to have a unique structure consisting of the amino acid sequence GKGGRAKDC-GG-D(KLAKLAK)2. The nine amino acid sequence CKGGRAKDC may exhibit a specific affinity to the ANXA2-prohibitin receptor system found in the blood vessels supporting white adipose cells.[4] The researchers utilized phage display, a technique that is considered to enable the identification of specific peptide motifs, to isolate a peptide sequence CKGGRAKDC. Moreover, the CKGGRAKDC peptide appears to associate with a membrane protein called prohibitin, which has been identified as a potential vascular marker of adipose tissue. By directing a proapoptotic peptide towards prohibitin in the adipose vasculature, the researchers induced the ablation (removal) of white fat. This resulted in the possible resorption of established white adipose tissue and the potential normalization of metabolism. As a consequence, rapid obesity reversal was reported to be achieved. It is suggested that prohibitin is expressed in the blood vessels of white fat. However, it is crucial to note that the study solely focuses on elucidating the mechanisms involved and did not provide any definitive suggestions or implications regarding its potential.

 At the same time, (KLAKLAK)2 may disrupt mitochondrial membranes upon receptor-mediated cell internalization and possibly cause programmed cell death. As Adipotide may bind to prohibitin in white adipose vasculature, it potentially triggers apoptosis and hypothetically results in the ablation of white fat cells. According to research, Adipotide and other similar peptidomimetics may hold potential for reducing both subcutaneous and visceral fat and may even target intra-organ fat, such as in fatty liver.[5] In fact, the researchers posit that “vascular-targeted nanotherapy has the potential to contribute to the control of adipose function and ectopic fat deposition associated with obesity and the metabolic syndrome.”

References

  1. Kolonin, M. G., Saha, P. K., Chan, L., Pasqualini, R., & Arap, W. (2004). Reversal of obesity by targeted ablation of adipose tissue. Nature medicine, 10(6), 625–632. https://doi.org/10.1038/nm1048
  2. Staquicini, F. I., Cardó-Vila, M., Kolonin, M. G., Trepel, M., Edwards, J. K., Nunes, D. N., Sergeeva, A., Efstathiou, E., Sun, J., Almeida, N. F., Tu, S. M., Botz, G. H., Wallace, M. J., O’Connell, D. J., Krajewski, S., Gershenwald, J. E., Molldrem, J. J., Flamm, A. L., Koivunen, E., Pentz, R. D., … Arap, W. (2011). Vascular ligand-receptor mapping by direct combinatorial selection in cancer patients. Proceedings of the National Academy of Sciences of the United States of America108(46), 18637–18642. https://doi.org/10.1073/pnas.1114503108
  3. Salameh, A., Daquinag, A. C., Staquicini, D. I., An, Z., Hajjar, K. A., Pasqualini, R., Arap, W., & Kolonin, M. G. (2016). Prohibitin/annexin 2 interaction regulates fatty acid transport in adipose tissue. JCI insight1(10), e86351. https://doi.org/10.1172/jci.insight.86351
  4. Kolonin, M. G., Saha, P. K., Chan, L., Pasqualini, R., & Arap, W. (2004). Reversal of obesity by targeted ablation of adipose tissue. Nature medicine10(6), 625–632. https://doi.org/10.1038/nm1048
  5. Hossen, N., Kajimoto, K., Akita, H., Hyodo, M., & Harashima, H. (2013). A comparative study between nanoparticle-targeted therapeutics and bioconjugates as obesity medication. Journal of controlled release : official journal of the Controlled Release Society171(2), 104–112. https://doi.org/10.1016/j.jconrel.2013.07.013
  6. Allott, E. H., Masko, E. M., & Freedland, S. J. (2013). Obesity and prostate cancer: weighing the evidence. European urology63(5), 800–809. https://doi.org/10.1016/j.eururo.2012.11.013
  7. Hossen, N., Kajimoto, K., Akita, H., Hyodo, M., & Harashima, H. (2013). A comparative study between nanoparticle-targeted therapeutics and bioconjugates as obesity medication. Journal of controlled release : official journal of the Controlled Release Society, 171(2), 104–112. https://doi.org/10.1016/j.jconrel.2013.07.013
  8. Barnhart, K. F., Christianson, D. R., Hanley, P. W., Driessen, W. H., Bernacky, B. J., Baze, W. B., Wen, S., Tian, M., Ma, J., Kolonin, M. G., Saha, P. K., Do, K. A., Hulvat, J. F., Gelovani, J. G., Chan, L., Arap, W., & Pasqualini, R. (2011). A peptidomimetic targeting white fat causes weight loss and improved insulin resistance in obese monkeys. Science translational medicine, 3(108), 108ra112. https://doi.org/10.1126/scitranslmed.3002621
  9. Thuaud, F., Ribeiro, N., Nebigil, C. G., & Désaubry, L. (2013). Prohibitin ligands in cell death and survival: mode of action and therapeutic potential. Chemistry & biology, 20(3), 316–331. https://doi.org/10.1016/j.chembiol.2013.02.006

 

 

 

REQUEST MORE DETAILS
Please fill out the form below and click the button to request more information about
FirstName*
LastName*
Email*
Message*
Leave a message
FirstName*
LastName*
Email*
Message*
Message Us